phase ib/iia study of azd4573 and acalabrutinib in patients with r/r dlbcl
Published 1 year ago • 46 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:08
overview of the phase i study with acalabrutinib (acp-196) in cll
-
1:46
phase ii study of acalabrutinib plus rice in r/r dlbcl
-
1:36
the use of tafasitamab and lenalidomide in r/r dlbcl
-
4:43
phase ib trial of ianalumab plus ibrutinib for cll
-
4:08
phase ib trial of ianalumab plus ibrutinib for cll
-
4:37
alpha solutions at home - capillary blood collection kit
-
11:47
ib biology internal assessment (ia) analysis
-
40:20
high-risk mds follonig car t cells in patients with rr dlbcl
-
1:39
phase i/ii trial of adct-602 in b-all
-
1:22
glofitamab as a soc in third-line dlbcl and its potential in earlier lines of therapy
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
1:58
introduction to aiforia's clinical solutions
-
0:09
apical 4-chamber view at the time of atypical rbbb - supplementary video 2 [id 269576]
-
1:03
ib biology all of topic 4.2 in 60 seconds
-
0:12
apical 2-chamber view at the time of atypical rbbb - supplementary video 5 [id 269576]
-
53:17
cutting through skincare bs: an evaluation framework.
-
13:20
a phase 3 study of biosimilar bi 695501 versus adalimumab in patients with crohn’s disease - vjbm